Search results
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Motley Fool· 12 months agoVertex Pharmaceuticals (NASDAQ: VRTX) is already a rock star in the world of cystic fibrosis (CF)...
Vertex Pharmaceuticals Stock: Bear vs. Bull
Motley Fool· 10 months agoVertex Pharmaceuticals (NASDAQ: VRTX) is heading toward a big moment: a regulatory decision on what may become its next game-changing product. Investors...
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 2 weeks agoVertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...
Vertex Rebounds — But Its Alternative To Opioids Is 'Not A Game-Changer,' Says Analyst
Investor's Business Daily· 3 months agoVertex Pharmaceuticals' alternative to opioids in pain treatment is "not a game-changer," an analyst...
Vertex 2024: see how HaZ Dulull blurs the line between film and video games in Unreal Engine
Creative Bloq via Yahoo News· 2 months agoHaZ Dulull . At HaZimation, HaZ Dulull and his team produce animated feature films, series and video...
Vertex, the ultimate event for 2D and 3D artists, returns in 2024
Creative Bloq via Yahoo News· 5 months agoVertex; a logo on a complex designed background. It's been a long time coming but our Vertex...
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has been generating billion-dollar revenue for years, thanks...
Vertex 2024 speaker: Moog Gravett on cinematics and technical art
Creative Bloq via Yahoo News· 2 months agoVertex 2024 speaker Moog Gravett. After working in the video games industry since the early 2000s,...
Here's the No. 1 Reason to Buy Vertex Pharmaceuticals Now
Motley Fool· 2 years agoVertex Pharmaceuticals (NASDAQ: VRTX) is known for its blockbuster cystic fibrosis treatments. The...
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?
Motley Fool· 12 months agoVertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment. The...
